3 completed, 2 terminated, 1 withdrawn. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 3, Terminated 2, Withdrawn 1 |
Follow laquinimod: new trials by email Literature Review of laquinimod trials Research Report on laquinimod
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Multiple Sclerosis (3) · Multiple Sclerosis, Relapsing-Remitting (1) · Recurrence (1)
Teva Branded Pharmaceutical Products R&D, Inc. (6)
Bulgaria (5) · Czechia (5) · Estonia (5) · Georgia (5) · Germany (5) · Israel (5) · Italy (5) · Poland (5) · Romania (5) · Russia (5) · Spain (5) · Ukraine (5) · United States (5) · Lithuania (4) · Austria (3)
Giancarlo Comi (1) · Giancarlo Comi, Prof., MD (1) · Prof. Timothy Vollmer, MD (1)
PMID 26000222, PMID 22417253, PMID 24029546, PMID 34378456, PMID 36163349
2009 (2)